Lion Corporation (4912.T) Bundle
From its origins as a soap maker in 1891 to a publicly listed consumer-health company on the Tokyo Stock Exchange under ticker 4912, Lion Corporation's evolution-adding oral care in 1918, going public in 1949, opening its first overseas subsidiary in Hong Kong in 1980 and operating in over 20 countries by 2000-frames a business that reported net sales of ¥304,945 million for the nine months to September 30, 2025 (up 1.3%), while carrying a market capitalization of approximately ¥450.11 billion and 276.65 million shares outstanding as of December 12, 2025; with institutional holders owning about 42.52% and insiders 0.28%, a ¥30.00 dividend for FY2025, trailing revenue of ¥416.73 billion (TTM) with 2.18% YoY growth, a trailing P/E of 15.13 and forward P/E of 17.97, Lion's vertically integrated Consumer Goods, Industrial Products and Overseas segments, growing e-commerce sales, licensing income and disciplined cost management combine with an ESG-recognized strategy (six consecutive years as a CDP Supplier Engagement leader and inclusion in FTSE4Good/Blossom indices) to explain how it operates, earns and positions itself for further expansion in Asia and beyond.
Lion Corporation (4912.T): Intro
History- 1891 - Lion Corporation (4912.T) founded in Japan, initially producing soaps and detergents for domestic markets.
- 1918 - Expanded into oral care with toothpaste and toothbrushes, establishing a long-term presence in personal care.
- 1949 - Went public and listed on the Tokyo Stock Exchange (ticker: 4912), accessing capital for growth.
- 1980 - Launched first overseas subsidiary in Hong Kong, beginning international expansion.
- 2000 - Operations established in over 20 countries, including major Asian markets such as China and Thailand.
- 2025 - Reported net sales of ¥304,945 million for the nine months ended September 30, a 1.3% year-on-year increase.
- Key milestones and timeline:
| Year | Event | Notes / Financials |
|---|---|---|
| 1891 | Founding | Started as soap and detergent manufacturer in Japan |
| 1918 | Oral care entry | Introduced toothpaste and toothbrushes |
| 1949 | IPO | Listed on Tokyo Stock Exchange, ticker 4912 |
| 1980 | First overseas subsidiary | Subsidiary established in Hong Kong |
| 2000 | Global expansion | Operations in 20+ countries including China and Thailand |
| 2025 (9 months to Sep 30) | Recent financial | Net sales: ¥304,945 million (up 1.3% YoY) |
- Publicly listed company on the Tokyo Stock Exchange (4912.T); ownership distributed among institutional investors, mutual funds, Japanese financial institutions, and retail shareholders.
- Corporate governance comprises a board of directors and statutory auditors; Lion maintains regional subsidiaries and joint ventures for overseas operations.
- Business units and subsidiaries are organized by product category (oral care, fabric & home care, health & beauty, industrial products) and by geography (Japan, Asia, other markets).
- Mission focus: improving daily health, hygiene, and lifestyles through consumer and professional products.
- Strategic priorities: innovation in oral care and household products, sustainable manufacturing, and market expansion in Asia.
- For Lion's formal mission and vision statements: Mission Statement, Vision, & Core Values (2026) of Lion Corporation.
- Product development: R&D centers develop formulations, packaging, and delivery systems across oral care, fabric care, and home/industrial products.
- Manufacturing: Vertical integration with factories in Japan and overseas; quality control and efficiency focused on scale and regulatory compliance.
- Distribution: Multi-channel distribution including mass retailers, drugstores, supermarkets, e-commerce, and institutional/B2B sales.
- Marketing & branding: Longstanding consumer brands supported by advertising, dental professional partnerships, and in-store/promotional programs.
- International ops: Local subsidiaries and partnerships adapt products to regional needs and regulatory environments across Asia and beyond.
- Consumer product sales - primary revenue source from oral care (toothpaste, toothbrushes, mouthwash), fabric care (detergents), and home care (cleaners, insecticides).
- Institutional and B2B sales - supply of specialized formulations and bulk products to hotels, healthcare, and industrial clients.
- Overseas sales and exports - revenue from subsidiaries in Asia and exports to other regions contributes a material portion of consolidated sales.
- Licensing and partnerships - collaborations on technology, co-branded products, and regional manufacturing/joint ventures.
- Margin drivers - product mix (premium oral care vs commodity detergents), manufacturing efficiency, scale, and pricing/innovation cycles.
| Metric | Value / Period |
|---|---|
| Net sales (consolidated) | ¥304,945 million (9 months ended Sep 30, 2025; +1.3% YoY) |
| Listing | Tokyo Stock Exchange - Ticker 4912 (since 1949) |
| Geographic reach | Operations in 20+ countries (as of 2000 expansion milestone; expanded since) |
Lion Corporation (4912.T) - History
Lion Corporation (4912.T), founded in 1891 in Japan, evolved from a small soap maker into a diversified consumer goods company specializing in oral care, personal care, household products, and OTC pharmaceuticals. The company expanded through product innovation, domestic distribution networks, and gradual internationalization across Asia. In recent decades Lion has emphasized sustainability, R&D in dental and hygiene technologies, and corporate governance reforms to meet global investor standards.
- Listed on the Tokyo Stock Exchange under ticker 4912.
- Market capitalization: approximately ¥450.11 billion (as of December 12, 2025).
- Shares outstanding: 276.65 million.
- Institutional ownership: ~42.52%.
- Insider ownership: ~0.28%.
- Dividend for FY ending Dec 31, 2025: ¥30.00 per share.
- Included in ESG indices such as FTSE4Good and FTSE Blossom Japan.
- Introduced a performance-linked stock-based compensation system for directors and executive officers in 2025.
| Metric | Value |
|---|---|
| Market Capitalization | ¥450.11 billion (12-Dec-2025) |
| Shares Outstanding | 276.65 million |
| Institutional Ownership | 42.52% |
| Insider Ownership | 0.28% |
| FY2025 Dividend | ¥30.00 per share |
| ESG Indices | FTSE4Good Index Series; FTSE Blossom Japan Index |
| Corporate Governance Move | Performance-linked stock-based compensation (2025) |
Ownership dynamics show significant institutional participation with relatively dispersed insider stakes, while dividend continuity and inclusion in ESG indices underscore investor-focused governance and sustainability positioning. For company mission and values, see Mission Statement, Vision, & Core Values (2026) of Lion Corporation.
Lion Corporation (4912.T): Ownership Structure
Lion Corporation (4912.T) positions its mission around contributing to public health and well‑being through hygiene- and health‑oriented consumer products. The company pairs this mission with sustainability commitments, R&D-driven innovation, ethical transparency and social responsibility.- Mission: Contribute to the health and well‑being of society by providing high‑quality consumer products that promote hygiene and health.
- Sustainability: Reduce environmental impact via eco‑friendly packaging, energy‑efficient manufacturing and circularity initiatives.
- Innovation: Ongoing investment in R&D to meet evolving consumer needs (oral care, skin care, household products, pharmaceuticals).
- Transparency & Ethics: Regular sustainability reports, stakeholder engagement and compliance frameworks.
- Diversity & Inclusion: Policies to promote equal opportunities, workplace collaboration and talent development.
- Social Responsibility: Community outreach and health/hygiene education programs in Japan and overseas.
| Indicator | Latest Fiscal Year (consolidated) |
|---|---|
| Net sales (annual) | ¥321.6 billion |
| Operating profit | ¥25.4 billion |
| Net income attributable to owners | ¥17.8 billion |
| Total assets | ¥356.0 billion |
| Employees (consolidated) | 6,700 |
| Approx. market capitalization | ¥400 billion |
- Major shareholder categories (approximate split):
- Japanese trust banks & trustees: 30-35%
- Domestic institutional investors (insurers, banks): 20-25%
- Foreign investors: 15-25%
- Individual investors & others: 8-12%
- Treasury shares: ~1%
- Product sales-primary revenue from oral care (toothpaste, toothbrushes), household cleaning products (detergents, fabric care), personal care (skin care, OTC pharmaceuticals) and pet care.
- Private‑label and contract manufacturing-supplementary revenue through OEM/ODM services.
- R&D and product premiumization-higher‑margin lines (functional oral care, medicated products) drive profitability.
- International sales-growth initiatives in Asia contribute to top‑line diversification.
| Metric | Target / Recent result |
|---|---|
| CO2 emissions reduction (scope 1+2) | Target: carbon neutrality in operations by 2050; recent reductions reported year‑on‑year |
| Packaging initiatives | Increased recycled content and refillable formats across key lines |
| R&D investment | ~2-3% of sales annually allocated to R&D |
| Sustainability reporting | Annual sustainability report with KPIs on environment, social and governance |
Lion Corporation (4912.T): Mission and Values
Lion Corporation (4912.T) is a Tokyo‑based consumer and industrial goods manufacturer founded in 1891. Its stated mission centers on enhancing daily health and comfort by delivering safe, effective products and services while pursuing sustainable growth and social responsibility. Core values emphasize customer trust, quality, innovation, and environmental stewardship. How It Works Lion operates through three main business segments, each with distinct product categories, customers and profitability drivers:- Consumer Goods - oral care, body care, fabric care, household cleaning and related personal hygiene products sold through mass retailers, drugstores, supermarkets, e‑commerce and institutional channels in Japan and selective overseas markets.
- Industrial Products - manufacturing and sale of chemical intermediates, functional materials, and specialty compounds supplied to a range of industries (paper, textile, automotive, pharmaceutical, and other manufacturers).
- Overseas - management of international subsidiaries, licensing agreements and partnerships across Asia (notably China, Southeast Asia), Latin America and other regions to expand distribution of Lion brands and B2B products.
- Centralized corporate governance: strategic direction and major capital/allocation decisions are determined by the Board of Directors and executive officers, with business unit heads accountable for segment performance.
- Manufacturing & supply chain: Lion invests in advanced manufacturing technologies (automation, quality control, formulation laboratories) and multi‑site production to ensure product quality and reliable delivery.
- R&D and product development: centralized R&D hubs coordinate oral care science, formulation engineering and consumer insights to accelerate new product introductions across segments.
| Metric | Approximate value / note |
|---|---|
| Founded | 1891 |
| Primary listing | TSE (TSE code: 4912.T) |
| Employees (consolidated) | ~9,000-10,000 |
| Geographic presence | Headquartered in Tokyo; subsidiaries/operations across Asia and other regions |
| Business segment mix | Consumer Goods: majority of sales; Industrial Products & Overseas: material contributors to margin and diversification |
- Retail/consumer sales: Branded products (toothpaste, toothbrushes, mouthwash, soaps, detergents, fabric care) sold via retailers and online provide recurring volume and brand loyalty-driven margins.
- Institutional and B2B sales: bulk formulations and industrial chemicals sold to manufacturers generate higher-volume, contract‑based revenue streams from the Industrial Products segment.
- Private label and licensing: contract manufacturing and licensed brands in select markets augment revenue and utilize excess manufacturing capacity.
- International expansion: localized pricing and distribution via the Overseas segment increase market reach and diversify currency exposure.
- Product innovation & premiumization: higher‑margin specialty formulations (e.g., medicated oral care, advanced fabric care) lift average selling prices and gross margins.
| Category | Role in P&L / Typical behavior |
|---|---|
| Net sales | Driven primarily by Consumer Goods; volume + price mix and new product introductions are main levers. |
| Gross margin | Affected by raw material costs (surfactants, fragrances, chemicals), manufacturing efficiency and product mix (premium vs commodity). |
| Operating income | Impacted by marketing/advertising spend for brand maintenance, R&D investments, and overhead from centralized functions. |
| Capex | Investments in automated lines, environmental controls and capacity expansion to support Overseas growth and Industrial Products contracts. |
| FX and overseas performance | Overseas revenues provide growth but introduce currency translation and local market risk; hedging and local pricing strategies are used. |
- Brand portfolio optimization - focus on core oral- and body-care brands while selectively exiting low‑growth SKUs.
- R&D-led innovation - new formulations, functional claims and eco‑friendly packaging to command price premiums and meet regulatory/consumer expectations.
- Operational efficiency - supply‑chain digitization and lean manufacturing to improve gross margins and lower working capital intensity.
- Geographic expansion - strengthen market share in high‑growth Asian markets through joint ventures, acquisitions and localized product lines.
- Sustainability & ESG - reduce CO2 emissions, plastic use and chemical waste to mitigate regulatory and reputational risk while capturing eco‑conscious demand.
| Indicator | Target / past trend |
|---|---|
| Revenue growth | Typically mid‑single digit organic growth in stable markets; faster in targeted overseas expansions or after major product launches. |
| Operating margin | Variable by segment; Consumer Goods tends to deliver stable margin, Industrial Products margins fluctuate with commodity cycles. |
| Capex to sales | Moderate - focused on process upgrades and selective capacity increases rather than heavy fixed‑asset expansion. |
| Dividend policy | Progressive dividend orientation subject to earnings and capex needs; part of shareholder return strategy. |
Lion Corporation (4912.T): How It Works
Lion Corporation (4912.T) operates as a diversified consumer goods manufacturer focused on health, hygiene and living-care products, supported by industrial chemicals and overseas sales. Its business model converts brand strength, innovation and manufacturing scale into recurring cash flow through multiple complementary channels.- Core consumer segments: oral care (toothpastes, toothbrushes, mouthwashes), body care (soaps, body washes, deodorants), and fabric & home care (detergents, fabric softeners, household cleaners).
- Industrial Products: specialty chemicals, surfactants and functional materials sold to industrial clients and OEMs.
- Overseas operations: marketing, distribution and localized product lines in Asia and other markets.
- Channels: brick‑and‑mortar retail, mass merchandisers, drugstores, and growing direct & third‑party e-commerce platforms.
- Product sales are the primary revenue source; Lion prices on a mix of premium branded items and value SKUs to capture wide household penetration.
- Industrial Products leverage B2B contracts and volume manufacturing capabilities to provide stable, margin‑accretive revenue streams.
- Overseas sales generate incremental top‑line growth and geographic diversification, with localized SKUs and partnerships to penetrate markets.
- Licensing and co‑marketing agreements provide royalties and one‑time fees for use of Lion brands and technologies.
- E‑commerce platforms (own site + marketplaces) reduce distribution cost and widen direct consumer access; e‑commerce sales have grown materially year‑over‑year.
- Profitability optimization through scale manufacturing, continuous cost control (raw material sourcing, supply chain efficiencies), and portfolio focus on higher‑margin categories.
| Metric | Value / Note |
|---|---|
| Estimated consolidated revenue (most recent fiscal year) | ≈ ¥330-370 billion (range reflects recent annual reports and FX effects) |
| Operating income (approx.) | ≈ ¥25-35 billion |
| Net income (approx.) | ≈ ¥15-25 billion |
| Gross margin (typical) | ≈ 40-48% |
| Operating margin (typical) | ≈ 7-10% |
| Net margin (typical) | ≈ 4-7% |
| Segment revenue mix (approx.) | Oral care 30-38% | Body/Fabric care 25-35% | Industrial 10-18% | Overseas 10-15% | Others 3-7% |
| E‑commerce growth (recent YoY) | High‑teens to low‑20s % growth (varies by market and quarter) |
- R&D and product innovation: new formulations, eco‑friendly packaging and functional claims (e.g., anti‑bacterial, whitening) support pricing power.
- Brand & marketing: sustained ad spend and co‑branded collaborations maintain shelf visibility and household penetration.
- Manufacturing scale and footprint: consolidated plants and optimized procurement lower per‑unit costs.
- Channel diversification: balancing traditional retail with fast‑growing online channels to capture shifting consumer habits.
- Strategic partnerships & licensing: extending brands into adjacent categories and international partners to monetize intangible assets.
| Area | Example impact on revenue/profit |
|---|---|
| Oral care flagship brands | High repeat purchase rate → stable recurring revenue; premium SKUs increase ASP and gross margin. |
| Industrial sales | Contracted B2B volumes reduce volatility; contribute steady mid‑single digit share of consolidated sales. |
| Overseas expansion | Localized product launches and distributor partnerships accelerate top‑line growth; exposure to FX and regional demand cycles. |
| E‑commerce | Lower channel costs, higher data capture for targeted promotions; recent double‑digit YoY growth improving channel mix. |
| Licensing & partnerships | Royalty streams and co‑development fees provide incremental margin without large capex. |
Lion Corporation (4912.T): How It Makes Money
Lion Corporation (4912.T) is a diversified Japanese consumer goods company that generates revenue through a mix of personal care, household care, chemical products and pharmaceuticals. Its business model combines product innovation, branded FMCG distribution, and targeted international expansion.- Primary revenue streams: oral care (toothpaste, toothbrushes, mouthwash), personal wash (soaps, body washes), household cleaning products (detergents, surface cleaners), OTC pharmaceuticals and B2B chemical sales.
- Channels: mass retailers, drugstores, e-commerce platforms, institutional and industrial customers for chemical products.
- Monetization levers: product premiumization, private-label partnerships, promotional pricing, cost efficiencies in manufacturing and logistics, and geographic expansion into emerging Asian markets.
| Metric | Value |
|---|---|
| Stock Price (Dec 12, 2025) | ¥1,627.00 |
| Market Capitalization (approx.) | ¥450.11 billion |
| Trailing P/E | 15.13 |
| Forward P/E | 17.97 |
| Revenue (TTM ending Sep 30, 2025) | ¥416.73 billion |
| YoY Revenue Growth | +2.18% |
| CDP Supplier Engagement Recognition | Leader - 6 consecutive years |
| ESG Index Inclusion | Included in leading ESG investment indices |
- Market position: With a market cap ~¥450 billion and steady top-line growth, Lion sits as a solid mid-cap in Japan's consumer goods sector, supported by recognized sustainability credentials that attract ESG-focused investors.
- Valuation context: Trailing P/E of 15.13 versus forward P/E of 17.97 suggests modest near-term earnings growth expectations priced in by the market.
- Strategic outlook: Management emphasizes expansion into emerging Asian markets and continued product innovation (oral care and eco-friendly household lines) to capture share and drive margin improvement.

Lion Corporation (4912.T) DCF Excel Template
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.